1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Welcome back my Onc brothers and sisters.

Discussion in 'Ortho Biotech' started by Anonymous, Aug 29, 2014 at 4:05 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    We are now positioned to run JnJ again! Many of us had to be dispersed around to stay afloat. But we are back! I look forward to growing onward and upward with the powerhouse crew. Sell em and close em. Rack em and break em!